Highlights Apyx Medical Corporation

Equities

APYX

US03837C1062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.45 ^USD	-2.03%		+9.85%	-44.66%

Apr. 05	Archon Capital Management Engages with Apyx Medical Corporation	CI
Apr. 01	Stavros G. Vizirgianakis Engages in Discussions with Apyx Medical Corporation	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Apyx Medical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 21	CI
Apyx Medical Corporation Provides Earnings Guidance for the Year Ending December 31, 2024	Mar. 21	CI
Apyx Medical Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 21	CI
North American Morning Briefing : Investors -2-	Mar. 21	DJ
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication Evaluating the Safety of Renuvion® Following Liposuction in Multiple Areas of the Body	Jan. 22	CI
Apyx Medical Reports Q4, Full-Year 2023 Preliminary Revenue	Jan. 08	MT
Apyx Medical Corporation Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	Jan. 08	CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Posts Q3 Revenue $12M, vs. Street Est of $15.4M	Nov. 09	MT
Apyx Medical Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09	CI
Apyx Medical Corporation Revises Earnings Guidance for the Year 2023	Nov. 09	CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Reports Q2 Revenue $13.6M, vs. Street Est of $14.3M	23-08-10	MT
Apyx Medical Corporation Reaffirms Financial Guidance for the Year Ending December 31, 2023	23-08-10	CI
Apyx Medical Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Apyx Medical Corporation Announces FDA 510(k) Clearance for the Renuvion® Micro Handpiece	23-06-14	CI
Apyx Medical Corporation Updates Earnings Guidance for the Year Ending December 31, 2023	23-05-11	CI
Earnings Flash (APYX) APYX MEDICAL CORPORATION Posts Q1 Revenue $12.1M, vs. Street Est of $10.8M	23-05-11	MT
Apyx Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Apyx Medical Says FDA Clears Renuvion for Specific Use After Liposuction	23-05-02	MT
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion®? for Coagulation of Subcutaneous Soft Tissues Following Liposuction for Aesthetic Body Contouring	23-04-28	CI
Apyx Medical Corporation Provides Earning Guidance for the Year Ending December 31, 2023	23-03-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Apyx Medical Corporation

Equities

APYX

US03837C1062

Highlights

Filters